INTERACTION. Work to set up a center of competence for spinal cord injuries began four years ago. Since then, although COVID-19 has slowed progress, much has happened. For a start, a major knowledge survey about spinal cord injuries (SCIs) has just received the go-ahead, peer health coaches have been trained, and a network for younger researchers working on SCIs is being supported. Ryggmärgsskadecentrum is facilitated at Högsbo Hospital. It has…
Ingmar Skoog chosen as Senior Citizen of the Year
DISTINCTION. Professor Ingmar Skoog has been voted Senior Citizen of the Year. The honor is given by the magazine Senioren and is intended to recognize a person who has helped change how senior citizens are viewed or who has been a good example for others. Skoog has been very critical of how society has treated elderly people during the pandemic and was quick to argue that public authorities should listen…
New discovery about autophagy published in Nature
NEW STUDY. The protein VCP plays an important role in initiating the process of autophagy in the cell. This is the finding of researchers at the University of Gothenburg together with researchers at the University of Cambridge and AstraZeneca. Their study was recently published in the the journal Nature Chemical Biology. Autophagy is the process that the cell uses to remove harmful proteins and to recycle building blocks and energy. It…
Justin Schneiderman’s new assignment supports management in AI developments
AI NYTT. We can use artificial intelligence for many things, including for organizing otherwise unmanageable amounts of data or developing software that helps in interpreting information-rich high-resolution x-ray images. In order to assist Sahlgrenska Academy researchers in staying up-to-date on this fast-developing field, management has appointed Justin Schneiderman to serve as an AI advisor for the faculty. In recent years, both competence and infrastructure for AI have taken great steps…
New studies support blood test for early detection of Alzheimer’s disease
NEW STUDIES. In three recent publications in Molecular Psychiatry, Brain and JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for Alzheimer’s disease can detect the disease early and track its course, which has major implications for a potential use in clinical practice and treatment trials. “This is an extremely dynamic research field right now, thanks to the technological development and seminal scientific progress in the past…